Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration
Investigative Ophthalmology & Visual Science · 2024-10-15 · 65 (12) · 20
DOI: 10.1167/iovs.65.12.20 ↗At a glance
Übersichtsarbeit in Investigative Ophthalmology & Visual Science, published on 2024-10-15. Written by Siao Tang and 6 co-authors. Institution: Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China. Major MEDLINE topics: Complement Activation, Lipid Metabolism, Macular Degeneration. Cited 47 times so far (Crossref); 257 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Age-related macular degeneration (AMD) stands as a leading cause of severe visual impairment and blindness among the elderly globally. As a multifactorial disease, AMD's pathogenesis is influenced by genetic, environmental, and age-related factors, with lipid metabolism abnormalities and complement system dysregulation playing critical roles. This review delves into recent advancements in understanding the intricate interaction between these two crucial pathways, highlighting their contribution to the disease's progression through chronic inflammation, drusen formation, and retinal pigment epithelium dysfunction. Importantly, emerging evidence points to dysregulated lipid profiles, particularly alterations in high-density lipoprotein levels, oxidized lipid deposits, and intracellular lipofuscin accumulation, as exacerbating factors that enhance complement activation and subsequently amplify tissue damage in AMD. Furthermore, genetic studies have revealed significant associations between AMD and specific genes involved in lipid transport and complement regulation, shedding light on disease susceptibility and underlying mechanisms. The review further explores the clinical implications of these findings, advocating for a novel therapeutic approach that integrates lipid metabolism modulators with complement inhibitors. By concurrently targeting these pathways, the dual-targeted approach holds promise in significantly improving outcomes for AMD patients, heralding a new horizon in AMD management and treatment.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
- National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis…
- Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
Cite
APA
Tang, S., Yang, J., Xiao, B., Wang, Y., Lei, Y., Lai, D., & Qiu, Q. (2024). Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science, 65(12), 20. https://doi.org/10.1167/iovs.65.12.20
Vancouver
Tang S, Yang J, Xiao B, Wang Y, Lei Y, Lai D, et al. Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 2024;65(12):20. doi:10.1167/iovs.65.12.20
BibTeX
@article{Tang2024,
author = {Tang, Siao and Yang, Jiaqi and Xiao, Bingqing and Wang, Yani and Lei, Yiou and Lai, Dongwei and Qiu, Qinghua},
title = {Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
volume = {65},
number = {12},
pages = {20},
doi = {10.1167/iovs.65.12.20}
}
EUVIMED